Technology
New On Robinhood
Health

NGM Biopharmaceuticals

$13.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.36%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NGM and other stocks, options, ETFs, and crypto commission-free!

About

NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. Read More The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.

Employees
Headquarters
South San Francisco, California
Founded
2008
Market Cap
911.10M
Price-Earnings Ratio
Dividend Yield
Average Volume
130.38K
High Today
$13.99
Low Today
$13.33
Open Price
$13.91
Volume
101.05K
52 Week High
$18.75
52 Week Low
$12.00

Collections

Technology
New On Robinhood
Health
Biotechnology
Therapy
2019 IPO
US
North America

Earnings

-$1.45
-$1.29
-$1.13
-$0.97
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 16, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.